Despite Election Outcome Uncertainty, Medicare Advantage Players Have Little to Fear

With ballots still being counted in battleground states at press time, the outcome of the Nov. 3 presidential election was still too close to call. Meanwhile, it looked like Republicans will barely hold onto their majority in the Senate, while Democrats will continue to control the House. Nevertheless, analysts and investors seemed relatively confident in the positioning of managed care organizations, especially those with a stake in Medicare Advantage.

“We have seen enough to say that the election is shaping up well for Managed Care stocks,” wrote SVB Leerink analyst Stephen Tanal on Nov. 4. The firm reiterated its “bullish outlook” on publicly traded firms with minimal Affordable Care Act exposure, namely those with a diversified portfolio (e.g., Anthem, Inc. and UnitedHealth Group) and MA-focused Humana Inc. He added that the “final outcome in the Senate will be important for investor sentiment on Medicaid-focused MCOs that derive more of their earnings from ACA-related programs,” notably Centene Corp. and Molina Healthcare, Inc.

© 2022 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

hhs-headquater
May 19

PHE Unwinding Delay Gives States, MCOs Time to Ease Transitions

READ MORE
generic-charts-on-tablets
May 19

Medicaid Rolls Soar to Nearly 89 Million Beneficiaries as Redeterminations Loom

READ MORE
happy-older-couple-looking-at-tablet
May 19

Segmented, Personalized Outreach Drives MAO Retention Efforts

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today